## Background: There is controversy regarding the effect of age on breast carcinoma, and previous analyses have often excluded the most elderly patients as well as those with advanced cancers. this study assessed treatment variations and outcome in relation to age for a complete series of patients
Age-related differences in the quality of life of breast carcinoma patients after treatment
β Scribed by Lari B. Wenzel; Diane L. Fairclough; Marianne J. Brady; David Cella; Kathleen M. Garrett; Brenda C. Kluhsman; Lori A. Crane; Alfred C. Marcus
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 89 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
The objective of this study was to compare the quality of life (QOL) of younger (Υ 50 years) versus older (ΟΎ 50 years) women on recent completion of treatment of breast carcinoma.
METHODS.
Data reported herein were obtained from a baseline assessment of 304 breast carcinoma patients. These patients were enrolled in a multiinstitutional, randomized trial testing a psychosocial telephone counseling intervention for breast carcinoma patients immediately after treatment. The assessment was made using a self-administered (mail) questionnaire, with an overall response rate of 86%. Included in this questionnaire were standardized measures of QOL using the Functional Assessment of Cancer Therapy-Breast instrument, the Center for Epidemiologic Studies Depression Scale, and the Impact of Event Scale.
RESULTS.
Comparisons of baseline data analyzed according to age approximating menopausal status (Υ 50 years and ΟΎ 50 years) indicated that younger women reported significantly greater QOL disturbance. QOL was significantly worse for younger women globally (P Ο 0.021), and with regard to domains of emotional well-being (P Ο 0.0002) and breast carcinoma specific concerns (P Ο 0.022).
Furthermore, symptoms of depression (P Ο 0.041) and disease specific intrusive thoughts (P Ο 0.013) were significantly worse for younger women. No significant sexual dysfunction or body image differences were noted.
CONCLUSIONS.
Results from this analysis suggest that younger women with breast carcinoma should be considered to be at high risk for QOL disruption and significant clinical distress. Targeted interventions for this cohort are recommended.
π SIMILAR VOLUMES
prostate carcinoma on overall QOL in the two treatment groups. The PCTO-Q of Minnesota Medical School, Minneapolis, assessed the patients' perceptions of the incidence and severity of specific changes Minnesota. in bowel, urinary, and sexual functions. The test-retest reliability of the PCTO-Q in a
## BACKGROUND. Men with localized prostate carcinoma are faced with important treatment decisions, and quality of life (QoL) information has become a crucial element of decision making. The first objective of this study was to compare the early, health-related QoL (HRQoL) of men with localized pro
## Background: Research on hot flashes (hfs) after the diagnosis and treatment of breast carcinoma (bc) is scarce. to our knowledge, this research represents the second study of hf prevalence and severity in women with bc and the first study of 1) correlates of hf prevalence and severity, 2) use of